Galecto shareholders approve reverse stock split and elect Anne Prener to board

Damora Therapeutics, Inc.

Director Anne Prener elected with 10,651,770 for, 711,618 withheld; 5,840,793 broker non-votes.
Reverse stock split approved (ratio 1:4 to 1:25, board to decide within one year): 15,283,182 for, 1,830,713 against.
Ratification of EY as auditor for FY2024 passed with 16,927,703 for, 197,148 against.
Total shares entitled to vote: 27,112,697; 17,204,181 present or represented.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.